Pacemaker‐associated superior vena cava syndrome: Role of contrast echocardiography

Pacemaker‐associated superior vena cava (SVC) syndrome is increasingly recognized as a nonmalignant type of SVC syndrome. Computed tomographic (CT) angiography is the first choice of imaging for diagnosis but in some cases there is discrepancy between the clinical findings and CT images. In this rep...

Full description

Saved in:
Bibliographic Details
Published in:Echocardiography (Mount Kisco, N.Y.) N.Y.), 2022-04, Vol.39 (4), p.647-653
Main Authors: Akin, Yesim, Cagli, Kumral, Okten, Riza Sarper, Keles, Telat, Golbasi, Zehra
Format: Article
Language:English
Subjects:
contrast study
Echocardiography
Echocardiography, Transesophageal
Humans
Pacemaker, Artificial - adverse effects
superior vena cava
Superior Vena Cava Syndrome - diagnostic imaging
Superior Vena Cava Syndrome - etiology
Vena Cava, Superior - diagnostic imaging
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pacemaker‐associated superior vena cava (SVC) syndrome is increasingly recognized as a nonmalignant type of SVC syndrome. Computed tomographic (CT) angiography is the first choice of imaging for diagnosis but in some cases there is discrepancy between the clinical findings and CT images. In this report we present the role of contrast study with transesophageal echocardiography in a patient with suspicion of SVC syndrome but inconclusive CT findings.
ISSN:0742-2822
1540-8175
DOI:10.1111/echo.15342